Blockbuster drug The European Patent Office has upheld a patent owned by Novo Nordisk
None of the study participants used any antidiabetic medications within the past six months of the study commencement and were considered new users. However, these patients received semaglutide prescriptions due to a history of hypertension, obesity, hypercholesterolemia, heart disease, or stroke
Similar content being viewed by others Introduction Obesity is a chronic, relapsing disease marked by adipocyte hypertrophy, low-grade inflammation, and progressive insulin resistance that together disrupt endocrine homeostasis 1,2
When you come off the drug, your hunger comes roaring backbut your muscle mass may already be lower
Maintaining a balanced and calorie-controlled diet can help mitigate this side effect